BridgeBio Pharma Inc. (BBIO) Tops Q1 EPS by 72c

BridgeBio Pharma Inc. (NASDAQ: BBIO) reported Q1 EPS of ($0.20), $0.72 better than the analyst estimate of ($0.92).

For earnings history and earnings-related data on BridgeBio Pharma Inc. (BBIO) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24